Core Insights - Cannara Biotech Inc. has received preliminary acceptance from the Société Québécoise du Cannabis (SQDC) for five vape cartridge products, set to be distributed across all retail stores in Québec starting November 2025 [1][2] - The company aims to leverage its expertise in producing premium live resin vape cartridges, which have no additives, to establish a strong presence in the Québec market [2][4] Company Overview - Cannara Biotech is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec with a total area of over 1,650,000 sq. ft. and a potential annual cultivation output of 100,000 kg [1][6] - The company focuses on producing affordable premium cannabis products, benefiting from Québec's low electricity costs [6] Market Opportunity - The SQDC reported revenues of $741.5 million for the Québec cannabis market in 2024, indicating significant market potential [3] - A survey revealed that 25% of Québec consumers vaped in the past year, with 28% of those doing so at least weekly, suggesting a growing consumer base for vape products [3] Product Launch - Cannara's entry into the live rosin vape cartridge category represents a significant milestone, utilizing high-quality flower inputs that are grown and extracted in-house [4][5] - The launch is seen as a culmination of extensive research and development efforts, focusing on genetic selection and process refinement [5]
Cannara Secures 5 Key Listings in Québec's New Vape Cartridge Category Including to be Released Live Rosin Vapes
GlobeNewswire News Room·2025-07-24 11:00